Jeff Dallager, VP and Corporate Controller at ST JUDE MEDICAL INC (STJ), sold 401 shares at $67.44 ($27K) on 2014-12-19, disclosed to the SEC on 2014-12-23.
Scheduled sale ($27k) by VP and Corporate Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| STJ | SELL | 2014-10-31 | $1.2M | — | Filing → |